High Pathogenicity of Nipah Virus from Pteropus lylei Fruit Bats, Cambodia.

CSUR381 Cambodia NiV-Malaysia genotype Nipah virus Pteropus bats Pteropus lylei animal model emerging infection fruit bats hamster henipavirus pathogenicity phosphoprotein phylogenetic analysis sequencing spillover viruses zoonoses

Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
01 2020
Historique:
entrez: 20 12 2019
pubmed: 20 12 2019
medline: 6 3 2021
Statut: ppublish

Résumé

We conducted an in-depth characterization of the Nipah virus (NiV) isolate previously obtained from a Pteropus lylei bat in Cambodia in 2003 (CSUR381). We performed full-genome sequencing and phylogenetic analyses and confirmed CSUR381 is part of the NiV-Malaysia genotype. In vitro studies revealed similar cell permissiveness and replication of CSUR381 (compared with 2 other NiV isolates) in both bat and human cell lines. Sequence alignments indicated conservation of the ephrin-B2 and ephrin-B3 receptor binding sites, the glycosylation site on the G attachment protein, as well as the editing site in phosphoprotein, suggesting production of nonstructural proteins V and W, known to counteract the host innate immunity. In the hamster animal model, CSUR381 induced lethal infections. Altogether, these data suggest that the Cambodia bat-derived NiV isolate has high pathogenic potential and, thus, provide insight for further studies and better risk assessment for future NiV outbreaks in Southeast Asia.

Identifiants

pubmed: 31855143
doi: 10.3201/eid2601.191284
pmc: PMC6924896
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104-113

Références

PLoS One. 2012;7(2):e32157
pubmed: 22393386
BMC Vet Res. 2019 Mar 4;15(1):73
pubmed: 30832676
Ann Neurol. 2002 Jun;51(6):703-8
pubmed: 12112075
Ann Neurol. 2007 Sep;62(3):235-42
pubmed: 17696217
J Infect Dis. 2019 May 24;219(12):1867-1878
pubmed: 30364984
Expert Rev Anti Infect Ther. 2015 Mar;13(3):343-54
pubmed: 25634624
Emerg Infect Dis. 2006 Dec;12(12):1888-94
pubmed: 17326940
Emerg Infect Dis. 2012 Mar;18(3):536-7
pubmed: 22377109
J Comp Pathol. 2007 May;136(4):266-72
pubmed: 17498518
PLoS One. 2012;7(3):e30538
pubmed: 22396728
Emerg Infect Dis. 2005 Jul;11(7):1042-7
pubmed: 16022778
Semin Cell Dev Biol. 2012 Feb;23(1):116-23
pubmed: 22227101
J Virol. 2006 Aug;80(15):7546-54
pubmed: 16840334
Nat Commun. 2015 Jun 24;6:7483
pubmed: 26105519
J Gen Virol. 2000 Aug;81(Pt 8):1927-32
pubmed: 10900029
Mol Phylogenet Evol. 2016 Apr;97:196-212
pubmed: 26826601
Global Health. 2017 Feb 8;13(1):9
pubmed: 28179007
Vector Borne Zoonotic Dis. 2017 Apr;17(4):271-274
pubmed: 28103156
BMC Vet Res. 2015 Mar 28;11:81
pubmed: 25880385
Emerg Infect Dis. 2005 Dec;11(12):1949-51
pubmed: 16485487
Clin Infect Dis. 2009 Dec 1;49(11):1743-8
pubmed: 19886791
J Comp Pathol. 2002 Feb-Apr;126(2-3):124-36
pubmed: 11945001
Science. 2000 May 26;288(5470):1432-5
pubmed: 10827955
Emerg Infect Dis. 2014 Jun;20(6):1064-6
pubmed: 24865545
PLoS Pathog. 2010 Oct 28;6(10):e1001168
pubmed: 21060819
Virology. 2008 Mar 15;372(2):357-71
pubmed: 18054977
Antiviral Res. 2013 Oct;100(1):38-43
pubmed: 23911335
Emerg Infect Dis. 2002 Sep;8(9):987-8
pubmed: 12194780
Ecol Evol. 2019 Mar 13;9(7):4181-4191
pubmed: 31015997
Proc Natl Acad Sci U S A. 2013 Feb 26;110 Suppl 1:3681-8
pubmed: 22936052
Nat Commun. 2012 Apr 24;3:796
pubmed: 22531181
J Infect Dis. 2015 Oct 1;212 Suppl 2:S372-8
pubmed: 26232760
J Mol Evol. 1987;26(3):205-11
pubmed: 3129568
Int Rev Immunol. 2017 Mar 4;36(2):108-121
pubmed: 28060559
J Virol. 1968 Oct;2(10):955-61
pubmed: 4302013
J Virol Methods. 2010 Nov;169(2):365-74
pubmed: 20709108
Lab Invest. 2001 Dec;81(12):1717-27
pubmed: 11742042
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904
Am J Pathol. 2003 Nov;163(5):2127-37
pubmed: 14578210
Science. 1995 Apr 7;268(5207):94-7
pubmed: 7701348
PLoS Pathog. 2012;8(8):e1002836
pubmed: 22879820
Int J Epidemiol. 2019 Aug 1;48(4):1219-1227
pubmed: 30977803

Auteurs

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH